| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.0035 | 1 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.008 | 1 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.0006 | 1 |